BIOMAT Database Logo BIOMAT Database Logo

Postprandial metabolism of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in humans. 2013

Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
Department of Biochemistry and Food Chemistry, University of Turku, Turku 20014, Finland. kaisa.linderborg@utu.fi

The study of the metabolism of docosapentaenoic acid (DPA, 22:5n-3) in humans has been limited by the unavailability of pure DPA and the fact that DPA is found in combination with eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) in natural products. In this double blind cross over study, pure DPA and EPA were incorporated in meals served to healthy female volunteers. Mass spectrometric methods were used to study the chylomicron lipidomics. Plasma chylomicronemia was significantly reduced after the meal containing DPA compared with the meal containing EPA or olive oil only. Both EPA and DPA were incorporated into chylomicron TAGs, while there was less incorporation into chylomicron phospholipids. Lipidomic analysis of the chylomicron TAGs revealed the dynamic nature of chylomicron TAGs. The main TAG species that EPA and DPA were incorporated into were EPA/18:1/18:1, DPA/18:1/16:0 and DPA/18:1/18:1. There was very limited conversion of DPA and EPA to DHA and there were no increases in EPA levels during the 5h postprandial period after the DPA meal. In conclusion, EPA and DPA showed different metabolic fates, and DPA hindered the digestion, ingestion or incorporation into chylomicrons of the olive oil present in the meal.

UI MeSH Term Description Entries
D002914 Chylomicrons A class of lipoproteins that carry dietary CHOLESTEROL and TRIGLYCERIDES from the SMALL INTESTINE to the tissues. Their density (0.93-1.006 g/ml) is the same as that of VERY-LOW-DENSITY LIPOPROTEINS. Chylomicron
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005231 Fatty Acids, Unsaturated FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds. Fatty Acids, Polyunsaturated,Polyunsaturated Fatty Acid,Unsaturated Fatty Acid,Polyunsaturated Fatty Acids,Acid, Polyunsaturated Fatty,Acid, Unsaturated Fatty,Acids, Polyunsaturated Fatty,Acids, Unsaturated Fatty,Fatty Acid, Polyunsaturated,Fatty Acid, Unsaturated,Unsaturated Fatty Acids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015118 Eicosapentaenoic Acid Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families. 5,8,11,14,17-Eicosapentaenoic Acid,Icosapent,5,8,11,14,17-Icosapentaenoic Acid,Eicosapentanoic Acid,Timnodonic Acid,omega-3-Eicosapentaenoic Acid,Acid, Eicosapentanoic,omega 3 Eicosapentaenoic Acid
D050356 Lipid Metabolism Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS. Metabolism, Lipid
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D018592 Cross-Over Studies Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed) Cross-Over Design,Cross-Over Trials,Crossover Design,Crossover Studies,Crossover Trials,Cross Over Design,Cross Over Studies,Cross Over Trials,Cross-Over Designs,Cross-Over Study,Crossover Designs,Crossover Study,Design, Cross-Over,Design, Crossover,Designs, Cross-Over,Designs, Crossover,Studies, Cross-Over,Studies, Crossover,Study, Cross-Over,Study, Crossover,Trial, Cross-Over,Trial, Crossover,Trials, Cross-Over,Trials, Crossover

Related Publications

Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
Comparison of the bioavailability of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in the rat.
January 2014, Prostaglandins, leukotrienes, and essential fatty acids,
Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
Docosapentaenoic acid (DPA, 22:5n-3) ameliorates inflammation in an ulcerative colitis model.
July 2019, Food & function,
Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
Docosapentaenoic Acid (DPA, 22:5n-3) Alleviates Ulcerative Colitis via Modification of Gut Microbiota and Their Metabolism.
October 2022, Nutrients,
Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
Estradiol favors the formation of eicosapentaenoic acid (20:5n-3) and n-3 docosapentaenoic acid (22:5n-3) from alpha-linolenic acid (18:3n-3) in SH-SY5Y neuroblastoma cells.
January 2008, Lipids,
Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
The pathway from arachidonic to docosapentaenoic acid (20:4n-6 to 22:5n-6) and from eicosapentaenoic to docosahexaenoic acid (20:5n-3 to 22:6n-3) studied in testicular cells from immature rats.
January 2000, Biochimica et biophysica acta,
Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
Enrichment of Brain n-3 Docosapentaenoic Acid (DPA) and Retinal n-3 Eicosapentaenoic Acid (EPA) in Lambs Fed Nannochloropsis oceanica Microalga.
February 2023, Animals : an open access journal from MDPI,
Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
Nutritional Enhancement of Farmed Salmon Meat via Non-GMO Nannochloropsis Gaditana: Eicosapentaenoic Acid (EPA, 20:5 n-3), Docosapentaenoic Acid (DPA, 22:5 n-3) and Vitamin D3 for Human Health.
October 2020, Molecules (Basel, Switzerland),
Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
An experimental study on transcutaneous absorption of ethylesters of eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) in pigs.
January 1996, Acta veterinaria Scandinavica,
Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
Docosapentaenoic acid (22:5n-3): a review of its biological effects.
January 2011, Progress in lipid research,
Kaisa M Linderborg, and Gunveen Kaur, and Eliza Miller, and Peter J Meikle, and Amy E Larsen, and Jacquelyn M Weir, and Anu Nuora, and Christopher K Barlow, and Heikki P Kallio, and David Cameron-Smith, and Andrew J Sinclair
Oral docosapentaenoic acid (22:5n-3) is differentially incorporated into phospholipid pools and differentially metabolized to eicosapentaenoic acid in tissues from young rats.
May 2011, Lipids,
Copied contents to your clipboard!